Sarah Stapleton
Royal Marsden NHS Foundation Trust · 19 works · 621 citations · h-index 5
Top works
- Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced Malignancies
- Identification of factors limiting patient recruitment into phase I trials: A study from the Royal Marsden Hospital
- Insights into the experiences of patients with cancer in London: framework analysis of free-text data from the National Cancer Patient Experience Survey 2012/2013 from the two London Integrated Cancer Systems
- A study of motivations and expectations of patients seen in phase 1 oncology clinics
- The lived experience of men with advanced cancer in relation to their perceptions of masculinity: a qualitative phenomenological study
- 1886P Quantifying quality of informed consent (IC) in patients enrolled in phase I (ph I) oncology clinical trials with a validated instrument (QuIC Parts A, B) in a large United Kingdom phase I trials unit
- Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT)
- What is the impact of targeted therapies given within phase I trials on the cognitive function of patients with advanced cancer: a mixed-methods exploratory study conducted in an early clinical trials unit
- 28P A mixed methods longitudinal process evaluation and implementation study of ctDNA use to guide adjuvant chemotherapy decision-making in patients with colorectal cancer: A sub-study of the ongoing UK wide interventional TRACC part C trial
- Assessing cognitive toxicity in early phase trials ‐ What are we missing?
- Filling the gaps in informed consent for advanced cancer patients considering phase I oncology trials: An in-depth qualitative study of key stakeholders at a large United Kingdom phase I unit
- 104 A clinical audit to investigate the reasons patients fail to meet eligibility requirements for screening and entry into Phase I trials of anticancer targeted therapies
- CONSENT - A Randomised Controlled Trial of Enhanced Informed Consent Compared to Standard Informed Consent to Improve Patient Understanding of Early Phase Oncology Clinical Trials – GBM Cohort (Nonrandomised) Analysis
- Abstract P4-08-31: Withdrawn
- CONSENT: Randomized controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials.
- Quantifying patients’ motivations for phase I oncology trials and how expectations change at the first clinical consultation.
- Evaluation of support and information needs for patients with cancer in a phase I trials unit
- CN9 An exploratory qualitative study to describe the experience of using a question prompt list for patients in early phase clinical trials
- CN92 Implementation of integrated supportive and palliative care services for patients undergoing CAR-T therapy